Medicare Enrolled
Dr. Sudheer Ummadi, MD
Nephrology · Allen Park, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ummadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ummadi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ummadi
Dr. Sudheer Ummadi is a nephrology specialist in Allen Park, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ummadi performed 11,757 Medicare services across 1,747 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ummadi received a total of $7,532 from 38 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ummadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in MI
$7,532 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,757
Medicare services
Top 3% in MI for nephrology
1,747
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~588 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
8,096 | $0 | $1 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
815 | $64 | $95 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
783 | $278 | $475 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
691 | $48 | $95 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
151 | $231 | $400 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
133 | $53 | $145 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
118 | $234 | $400 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
117 | $40 | $81 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
115 | $58 | $130 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
110 | $106 | $180 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
86 | $953 | $1,886 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
53 | $123 | $238 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
53 | $97 | $135 |
| Monthly dialysis physician visit A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment. |
50 | $160 | $325 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
42 | $528 | $1,065 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $141 | $265 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
39 | $41 | $55 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
37 | $29 | $50 |
| Balloon dilation of dialysis access with radiologist review A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness. |
34 | $471 | $920 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
33 | $491 | $1,584 |
| Dialysis services, partial month (age 20+) Dialysis treatment provided for a partial month of service for patients aged 20 years or older. |
30 | $8 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $115 | $220 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
21 | $33 | $75 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
19 | $104 | $259 |
| Radiologist review of image for removal of obstructive material A radiologist reviews medical images to assist in the removal of obstructive material. |
18 | $184 | $342 |
| Mechanical removal of obstructive material from central venous tube This procedure involves the mechanical clearing of blockages or debris from a central venous catheter to restore its function. |
16 | $359 | $919 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $77 | $145 |
| Hemodialysis circuit clot removal and vessel dilation This procedure involves removing or dissolving a blood clot within the hemodialysis circuit and using a balloon to widen the dialysis access segment, with imaging review by a radiologist. |
12 | $1,832 | $3,421 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
80.9% medium
18.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,532
Total received (2018-2024)
Avg $1,076/year across 7 years
Top 11% in MI for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,770 (89.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$762 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,257
2023
$1,344
2022
$999
2021
$696
2020
$824
2019
$869
2018
$543
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$451
Bard Peripheral Vascular, Inc.
$427
Ardelyx, Inc.
$196
OPKO Pharmaceuticals, LLC
$178
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Fresenius USA Marketing, Inc.
$132
Novartis Pharmaceuticals Corporation
$109
Amgen Inc.
$105
Vifor Pharma, Inc.
$92
CALLIDITAS THERAPEUTICS US INC.
$77
AKEBIA THERAPEUTICS INC
$66
Travere Therapeutics, Inc.
$53
Otsuka America Pharmaceutical, Inc.
$53
Daiichi Sankyo Inc.
$40
Aurinia Pharma U.S., Inc.
$39
ANI Pharmaceuticals, Inc.
$27
Boston Scientific Corporation
$20
CORDIS US CORP.
$20
Lilly USA, LLC
$19
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,500
Vifor Pharma, Inc.
$674
Bard Peripheral Vascular, Inc.
$672
Relypsa, Inc.
$554
Fresenius USA Marketing, Inc.
$462
OPKO Pharmaceuticals, LLC
$456
Amgen Inc.
$409
Horizon Therapeutics plc
$270
CALLIDITAS THERAPEUTICS US INC.
$220
Ardelyx, Inc.
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$209
Baxter Healthcare
$163
Aurinia Pharma U.S., Inc.
$152
Mallinckrodt Hospital Products Inc.
$151
AKEBIA THERAPEUTICS INC
$150
Travere Therapeutics, Inc.
$148
BAXTER HEALTHCARE
$127
Otsuka America Pharmaceutical, Inc.
$118
Boston Scientific Corporation
$117
Novartis Pharmaceuticals Corporation
$109
Daiichi Sankyo Inc.
$87
Alnylam Pharmaceuticals Inc.
$67
Horizon Pharma plc
$60
GlaxoSmithKline, LLC.
$46
ANI Pharmaceuticals, Inc.
$46
Mallinckrodt Enterprises LLC
$45
Calliditas Therapeutics US Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$38
CORDIS US CORP.
$36
Alexion Pharmaceuticals, Inc.
$35
GENZYME CORPORATION
$29
Exeltis, USA Inc.
$24
Keryx Biopharmaceuticals, Inc.
$23
Lilly USA, LLC
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
Mallinckrodt LLC
$15
Shire North American Group Inc
$13
Top 3 companies account for 37.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Auryxia · BENLYSTA · CROSSER · FABRAZYME · FARXIGA · FLUENCY · GATTEX · GENERAL - ANGIOGRAPHY · GENERAL - ULTRASOUND · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · LUTONIX · LUTONIX Drug Coated Balloon · MYNXGRIP · Not Product Related · OXLUMO · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · ROTALINK · Rayaldee · Rayaldee (old) · Renal - PD · SAMSCA · SOLIRIS · Sterling · TARPEYO · TAVNEOS · Thiola · Ultomiris · Vafseo · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
126
Per 100K population
7.1
County median income
$59,521
Nearest hospital
BEAUMONT HOSPITAL - DEARBORN
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ummadi is a mixed practice specialist, with above-average Medicare volume (top 3% in MI), with low-engagement industry engagement in the top 11% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ummadi experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ummadi performed 8,096 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ummadi receive payments from pharmaceutical companies?
Yes. Dr. Ummadi received a total of $7,532 from 38 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ummadi's costs compare to other nephrologists in Allen Park?
Dr. Ummadi's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ummadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Allen Park
Browse nephrologists in Allen Park ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in MI
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in MI
Which MI nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Vifor Pharma, Inc. Payments to Doctors
See all physicians who received payments from Vifor Pharma, Inc.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology